Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)

Polycystic Ovarian Syndrome Clinical Trial

Official title:
Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)

Status Recruiting

Clinical Trial Summary

Clinical Trial Description

Our study is observational, we are observing data from routine measurements during IVF/ICSI. Our study does not assess IVF/ICSI as an intervention, we are evaluating the role of FSI and preovulatory count which are calculated by observing routine measurements during the IVF/ICSI procedure.

All women fulfilling the inclusion criteria will be invited to participate in the study. A written informed consent will be taken and only women signing the consent will be included in the study. Patients included in the study will be subjected to full history taking and clinical examination including general, abdominal and gynecological examination. This will be followed by a vaginal ultrasound scan to assess uterus, ovaries and any pelvic masses.

All women will go through the usual IVF/ICSI procedure explained below, our aim is to observe the antral follicle count, the pre-ovulatory count, and calculate the FORT.

On the second day of menstruation serum FSH, LH, Prolactin and Oestradiol will be assessed and the antral follicular count (AFC) will be assessed using a vaginal ultrasound scan. AFC will be defined as the number of follicles measuring 3-10mm.

All patients will have standard pituitary down-regulation protocol with GnRHa (Triptorelin 0.1mg, Decapeptyl® Ferring, Germany) day 7 after ovulation of previous cycle or on day 21 of the oral contraceptive cycles. GnRHa will be continued for 2 weeks. FSH (Fostimon ®IBSA) 150-300 IU/day will be administered until the day of HCG administration.

On the day of HCG administration, ovarian ultrasound scan will be performed using a transvaginal probe and the Preovulatory follicle count (PC) will be assessed, (PFC) is defined as number of follicles measuring≥16mm. FORT will be calculated as: (PFC) * 100/AFC.

The procedure will be cancelled if less than 3 follicles 16-20 mm in size are present 12 days after starting FSH despite doses reaching 450 IU. The cycle will be also cancelled if there is risk of ovarian hyperstimulation like massive ovarian enlargement or serum estradiol exceeds 3000pg/L Transvaginal oocyte retrieval will be performed 34-36 h after the administration of HCG. Oocytes will be fertilized either via IVF or ICSI based on the couple's history. Fertilization will be assessed 16-18 h after IVF or ICSI. Embryo transfers will be performed 3 days after oocyte retrieval. No more than three embryos per patient will be transferred; vaginal tablets containing progesterone (Prontogest® IBSA) administered 400 mg/day as luteal support from the day of the oocyte retrieval. Pregnancy will be defined as the appearance of an intrauterine gestational sac by vaginal ultrasound 5 weeks after embryo transfer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02190006
Study type	Observational
Source	Cairo University
Contact	AbdelGany MA Hassan, MRCOG, MD
Phone	00201017801604
Email	abdelgany2@gmail.com
Status	Recruiting
Phase	N/A
Start date	July 2014
Completion date	December 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02244567` - Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women	Phase 1
Completed	`NCT01672801` - Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT	N/A
Completed	`NCT01653743` - Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women	Phase 3
Completed	`NCT00579540` - Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels	N/A
Terminated	`NCT05084274` - Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program	N/A
Completed	`NCT03717935` - Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS	N/A
Withdrawn	`NCT01716429` - Healthy Eating for Reproductive Health: Greenville	N/A
Active, not recruiting	`NCT02896452` - Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
Recruiting	`NCT05146063` - LNK in Polycystic Ovary Syndrome With Insulin Resistance
Recruiting	`NCT06303219` - Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian Syndrome	N/A
Completed	`NCT02869750` - The Relationship Between Adipokines, Obesity and Insulin Resistance in Women With Polycystic Ovarian Syndrome
Completed	`NCT01237106` - In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS)	N/A
Completed	`NCT01185704` - Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)	Phase 3
Recruiting	`NCT04029805` - Evaluation of a Combination of a Plant Extract and a Probiotic on Glucidic Metabolism in Women With PCOS and High Insulin Levels	Phase 1/Phase 2
Completed	`NCT01675843` - Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian Syndrome	Phase 4
Completed	`NCT01577017` - The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)	Phase 3
Completed	`NCT00478504` - Letrozole Versus Clomifene Citrate for Ovulation Induction	Phase 4
Completed	`NCT05215223` - Effect of Whole Body Vibration on Insulin Resistance in Females With Polycystic Ovarian Syndrome	N/A
Completed	`NCT03358199` - LOD Before IVF/ICSI in PCOS Patients With High AMH	N/A
Completed	`NCT02436226` - Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS	Phase 4